Sana Biotechnology

gold arrow pointing upward forward
Biotech

Sana stock price triples after allogeneic cell therapy data drop

The data “pave the way for a potentially transformative cure,” for the 1.7 million Americans with type 1 diabetes, Citi analysts wrote Jan. 8.
Gabrielle Masson Jan 8, 2025 10:38am
team funding workforce workforce reductions cash runway

Sana strips back cancer, CNS programs while warning of layoffs

Nov 5, 2024 7:05am
Paragliding with Mount Rainier in the background

Cell-focused Sana scoops first CSO—Chutes & Ladders

Aug 30, 2024 8:30am
Small white blocks with black text that say Diabetes Type 1 in all caps surrounded by syringes containing a blue liquid th

Sana's engineered islet cells control glucose in diabetic monkey

Feb 15, 2024 2:55pm
quit fire layoff workforce reduction exit

Sana retreats from in vivo CAR-T delivery, lays off 29% of staff

Oct 11, 2023 5:00am
layoffs job cuts workforce reduction layoff

Sana tight-lipped on extent of latest round of layoffs

Sep 1, 2023 5:40am